Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Oncology Institute (TOI) Depreciation & Amortization - Total: 2021-2025

Historic Depreciation & Amortization - Total for Oncology Institute (TOI) over the last 5 years, with Q3 2025 value amounting to $1.0 million.

  • Oncology Institute's Depreciation & Amortization - Total rose 2575.0% to $1.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.0 million, marking a year-over-year increase of 2979.14%. This contributed to the annual value of $3.2 million for FY2024, which is 1145.25% up from last year.
  • Latest data reveals that Oncology Institute reported Depreciation & Amortization - Total of $1.0 million as of Q3 2025, which was up 2575.0% from $1.0 million recorded in Q2 2025.
  • Oncology Institute's Depreciation & Amortization - Total's 5-year high stood at $1.0 million during Q2 2025, with a 5-year trough of $165000.0 in Q1 2021.
  • In the last 5 years, Oncology Institute's Depreciation & Amortization - Total had a median value of $601000.0 in 2023 and averaged $603052.6.
  • Its Depreciation & Amortization - Total has fluctuated over the past 5 years, first soared by 13257.0% in 2023, then tumbled by 1247.26% in 2024.
  • Oncology Institute's Depreciation & Amortization - Total (Quarter) stood at $263000.0 in 2021, then soared by 74.9% to $460000.0 in 2022, then surged by 75.65% to $808000.0 in 2023, then increased by 15.47% to $933000.0 in 2024, then increased by 7.82% to $1.0 million in 2025.
  • Its last three reported values are $1.0 million in Q3 2025, $1.0 million for Q2 2025, and $1.0 million during Q1 2025.